Corcept Therapeutics Inc (NASDAQ: CORT) kicked off on Monday, down -8.51% from the previous trading day, before settling in for the closing price of $38.2. Over the past 52 weeks, CORT has traded in a range of $32.99-$117.33.
Annual sales at Healthcare sector company grew by 9.89% over the past five years. While this was happening, its average annual earnings per share was recorded -28.34%. With a float of $92.90 million, this company’s outstanding shares have now reached $105.12 million.
Corcept Therapeutics Inc (CORT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Corcept Therapeutics Inc is 11.68%, while institutional ownership is 74.70%. The most recent insider transaction that took place on Dec 02 ’25, was worth 1,601,526. In this transaction Chief Development Officer of this company sold 20,000 shares at a rate of $80.08, taking the stock ownership to the 1,235 shares. Before that another transaction happened on Dec 01 ’25, when Company’s insider sold 20,000 for $79.52, making the entire transaction worth $1,590,490. This insider now owns 7,904 shares in total.
Corcept Therapeutics Inc (CORT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.26 earnings per share (EPS), lower than consensus estimate (set at 0.42) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.41% during the next five years compared to 9.89% growth over the previous five years of trading.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Take a look at Corcept Therapeutics Inc’s (CORT) current performance indicators. Last quarter, stock had a quick ratio of 3.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.96. Likewise, its price to free cash flow for the trailing twelve months is 22.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.88, a number that is poised to hit 0.25 in the next quarter and is forecasted to reach 0.57 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
Corcept Therapeutics Inc (NASDAQ: CORT) saw its 5-day average volume 7.1 million, a positive change from its year-to-date volume of 5.95 million. As of the previous 9 days, the stock’s Stochastic %D was 5.72%.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 3.38%, which indicates a significant decrease from 3.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.12 in the past 14 days, which was higher than the 3.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $76.10, while its 200-day Moving Average is $73.72. Nevertheless, the first resistance level for the watch stands at $37.12 in the near term. At $39.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $40.40. If the price goes on to break the first support level at $33.84, it is likely to go to the next support level at $32.72. Assuming the price breaks the second support level, the third support level stands at $30.55.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
The company with the Market Capitalisation of 3.68 billion has total of 105,188K Shares Outstanding. Its annual sales at the moment are 675,040 K in contrast with the sum of 141,210 K annual income. Company’s last quarter sales were recorded 207,640 K and last quarter income was 19,670 K.
